The Clorox Company cash flow to debt ratio of 17.77% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

The Clorox Company's free cash flow has increased 57.56% from $483.00M last year to $761.00M, signaling increasing performance

The Clorox Company's debt to equity ratio is 61.33, which means that the company's assets are unhealthy financed, signaling financial risk.

The Clorox Company's debt has increased relative to shareholder equity from 8.97 last year to 61.33 today, signaling weakened financials

The Clorox Company has a net debt to EBITDA ratio of 5.84x, which exceeds the 3.00x threshold, indicating high leverage and potential financial risk

The Clorox Company's interest coverage ratio of 12.78 indicates that earnings with good margin can cover interest payments on company debt

The Clorox Company's profit margin has decreased (23.39%) in the last year from 11.40% to 8.74%, signaling decreasing performance

The Clorox Company's short-term liabilities of $2.77B exceed its short-term assets of $1.82B, signaling financial risk

The Clorox Company's return on assets of 7.53% is higher than the 5.00% threshold, indicating efficient asset utilization

The Clorox Company's return on equity of -1.89K%, is lower than 15.00%, indicating bad performance

The Clorox Company's operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation

The Clorox Company had positive net income in 5 out of 5 years, indicating stable and consistent earnings

The Clorox Company has positive free cash flow, indicating the company generates cash after capital expenditures

The Clorox Company has a free cash flow yield of 5.84%, which is above the 2.00% threshold, indicating strong cash generation relative to market value

The Clorox Company's yearly earnings has decreased 27.53% since last year from $810.00M to $587.00M, signaling decreasing performance

The Clorox Company's yearly revenue has decreased 5.41% since last year from $7.10B to $6.72B, signaling decreasing performance

ROIC 20.39% (Source: FMP key-metrics). At or above the 10% threshold. Score: 2 of 2. The company is generating returns above the upper end of the typical US weighted-average cost of capital range under this definition of invested capital.

The Clorox Company's 3-year revenue CAGR of -3.11% is negative, indicating declining revenue over the past 3 years

The Clorox Company had revenue growth in only 2 out of 5 years, indicating inconsistent revenue performance

The Clorox Company had positive ROE in 5 out of 5 years, indicating consistent and reliable returns on equity

The Clorox Company is overvalued relative to its fair value price of 24.61 based on Discounted Cash Flow model

The Clorox Company has an earnings yield of 4.48%, which is above the 4.00% threshold, indicating the stock offers reasonable value relative to its earnings

The Clorox Company is overvalued relative to its fair value price of 57.99 based on EBITDA multiple model

The Clorox Company has an EV/EBITDA ratio of 19.98x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings

The Clorox Company is overvalued relative to its fair value price of 44.45 based on Earnings Fair Value model

The Clorox Company's earnings growth over the measurement period is negative; the PEG ratio is not meaningful and the check fails.

The Clorox Company has a price-to-book ratio of 52.04x, which exceeds the 5.00x threshold, indicating the stock may be overvalued relative to its book value

The Clorox Company has a price-to-sales ratio of 1.95x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue